Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial

Matthew D. Galsky, Dean F. Bajorin, Yoshihiko Tomita, Dingwei Ye, Mads Agerbæk, Deborah Enting, Avivit Peer, Matthew I. Milowsky, Ko Kobayashi, Marc‐Oliver Grimm, Frank Stenner, Justin M. David, Jun Li, Scott D. Chasalow, Federico Nasroulah, Abraham Apfel, Keziban Ünsal-Kaçmaz, Andrea Necchi